BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4522531)

  • 1. Cellular immunity in human osteogenic sarcoma.
    Gangal SG; Agashe SS; Nair PN; Rao RS
    Indian J Cancer; 1973 Sep; 10(3):295-301. PubMed ID: 4522531
    [No Abstract]   [Full Text] [Related]  

  • 2. Cell mediated immunity in human osteogenic sarcoma.
    Agashe SS; Nair PN; Rao RS; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):61-6. PubMed ID: 1058832
    [No Abstract]   [Full Text] [Related]  

  • 3. Cell mediated immunity in osteogenic sarcoma. Role of the regional lymph nodes.
    Rao RS; Agashe SS; Nair PN; Gangal SG
    Indian J Cancer; 1975 Mar; 12(1):56-60. PubMed ID: 1058831
    [No Abstract]   [Full Text] [Related]  

  • 4. Disapperance of osteogenic sarcoma after irradiation: immunologic observations.
    Urtasun RC; Connachie PR
    J Can Assoc Radiol; 1976 Jun; 27(2):80-3. PubMed ID: 1066352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteogenic sarcoma. Immunologic parameters before and during immunotherapy with tumor-specific transfer factor.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO; Spitler LE
    J Clin Invest; 1975 Mar; 55(3):487-99. PubMed ID: 1078826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific cell-mediated immunity in household contacts of cancer patients.
    Byers VS; Levin AS; Hackett AJ; Fudenberg HH
    J Clin Invest; 1975 Mar; 55(3):500-13. PubMed ID: 1078827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies of cell mediated immunity to human sarcomas.
    Rella W; Kotz R; Vetterlein M
    Osterr Z Onkol; 1974; (3-4):89-96. PubMed ID: 4143396
    [No Abstract]   [Full Text] [Related]  

  • 8. Transfer factor therapy in osteogenic sarcoma.
    Levin AS; Byers VS; Fudenberg HH; Wybran J; Hackett AJ; Johnston JO
    Trans Assoc Am Physicians; 1974; 87():153-8. PubMed ID: 4549141
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxicity of lymphocytes to established cultures of human tumors: evidences for specificity.
    Sinkovics JG; Tebbi K; Cabiness JR
    Natl Cancer Inst Monogr; 1973 Jun; 37():9-18. PubMed ID: 4123456
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocyte and serum-mediated immunity in murine osteosarcoma.
    Miller CW; Fisher SJ
    J Bone Joint Surg Am; 1977 Oct; 59(7):981-3. PubMed ID: 269112
    [No Abstract]   [Full Text] [Related]  

  • 11. Cellular immunity to human sarcoma.
    Vánky F; Stjernswärd J; Nilsonne U
    J Natl Cancer Inst; 1971 Jun; 46(6):1145-51. PubMed ID: 4932427
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cellular immunity indices in osteogenic sarcoma].
    Rodionov SV
    Vopr Onkol; 1977; 23(11):18-23. PubMed ID: 271419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxicity of human peripheral lymphocytes for glioma, osteosarcoma, and glia cell lines.
    Skurzak H; Steiner L; Klein E; Lamon E
    Natl Cancer Inst Monogr; 1973 Jun; 37():93-102. PubMed ID: 4514736
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings: The thymic hormone and cellular immunity.
    Odling-Smee GW; Camblin JG; Roy AD
    Br J Surg; 1975 Feb; 62(2):162. PubMed ID: 1054283
    [No Abstract]   [Full Text] [Related]  

  • 15. Longitudinal studies of cellular immunity of patients with osteogenic sarcoma during chemoimmunotherapy.
    Sears HF; Simon R; Rosenberg SA
    Cancer Treat Rep; 1980; 64(4-5):589-97. PubMed ID: 6933004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of immunotherapy of human sarcomas: the need for an in vitro monitoring assay.
    Sinkovics JG; Campos LT; Kay HD; Loh KK; Cabiness JR; Ervin F
    Ann Clin Lab Sci; 1973; 3(6):414-23. PubMed ID: 4796444
    [No Abstract]   [Full Text] [Related]  

  • 17. Reactivity of lymphocytes from normal persons on cultured tumor cells.
    Takasugi M; Mickey MR; Terasaki PI
    Cancer Res; 1973 Nov; 33(11):2898-902. PubMed ID: 4748446
    [No Abstract]   [Full Text] [Related]  

  • 18. Tumor-specific cellular cytotoxicity to human sarcomas: evidence for a cell-mediated host immune response to a common sarcoma cell-surface antigen.
    Cohen AM; Ketcham AS; Morton DL
    J Natl Cancer Inst; 1973 Mar; 50(3):585-9. PubMed ID: 4513520
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study of cellular immunity indices in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA
    Vopr Onkol; 1973; 19(11):18-21. PubMed ID: 4522541
    [No Abstract]   [Full Text] [Related]  

  • 20. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.